NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF

NOVARTIS AG

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026

$150.20−0.42 (-0.28%)

Close on Oct 19, 2026

Market cap: $287.48B
P/E (TTM): 21.0
Dividend yield: –

NOVARTIS AG income statement

Annual QuarterlyTTM

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q2 2025 2025-06-30	Q2 2024 2024-06-30	Q2 2023 2023-06-30	Q2 2022 2022-06-30	Q2 2021 2021-06-30	Q2 2020 2020-06-30	Q2 2019 2019-06-30	Q2 2018 2018-06-30	Q2 2017 2017-06-30
Cost of Revenue	3,710	3,322	3,173	3,342	3,751	3,914	3,429	3,406	3,558	4,258
Gross Profit	11,241	11,514	9,699	8,403	9,334	9,380	8,193	8,618	8,095	8,236
Research & Development	2,847	2,727	2,367	2,304	2,498	2,400	2,441	2,051	2,126	2,062
Selling, General & Admin	3,241	3,442	3,091	3,091	3,581	3,754	3,368	3,585	3,495	3,806
Operating Income	4,750	4,864	4,014	2,807	2,228	3,479	2,352	2,663	2,431	2,280
Interest Expense	462	289	246	216	202	201	220	205	237	192
Income from Equity Investments	-2.00	-3.00	-2.00	-2.00	–	239	183	176	5,932	215
Pretax Income	4,269	4,531	3,841	2,674	2,042	3,506	2,288	2,634	8,171	2,315
Income Tax Expense	1,012	507	595	403	347	611	421	525	443	336
Income from Continuing Operations	–	–	3,246	2,271	–	–	1,867	2,109	7,728	–
Income from Discontinued Operations	–	–	–	46	–	–	–	4,691	40	–
Net Income incl. Noncontrolling Interests	3,257	4,024	3,246	2,317	1,695	2,895	1,867	6,800	7,768	1,979
Minority Interest in Earnings	-7.00	-17	0	1.00	1.00	-1.00	0	1.00	0	-1.00
Net Income	3,264	4,041	3,246	2,316	1,694	2,896	1,867	6,799	7,768	1,980
EPS (Basic)(per share)	1.71	2.07	1.60	1.11	0.77	1.29	0.82	2.94	3.34	0.84
EPS (Diluted)(per share)	1.71	2.06	1.59	1.11	0.77	1.28	0.81	2.91	3.31	0.83
Shares Outstanding (Basic, Weighted)(shares)	1,905	1,948	2,033	2,083	2,198	2,243	2,289	2,310	2,327	2,354
Shares Outstanding (Diluted, Weighted)(shares)	1,914	1,960	2,046	2,095	2,211	2,258	2,304	2,333	2,346	2,373

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: 31.0%

Financial strength

Current ratio: 0.86
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 24.0%

Valuation

P/E ratio: 21.0
Price to sales: –
Price to book: 6.92
Dividend yield: –